Literature DB >> 12221095

Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues.

Sarama Sathyaseelan Deepa1, Yuko Umehara, Shigeki Higashiyama, Nobuyuki Itoh, Kazuyuki Sugahara.   

Abstract

We previously observed that the cortical neuronal cell adhesion mediated by midkine (MK), a heparin (Hep)-binding growth factor, is specifically inhibited by oversulfated chondroitin sulfate-E (CS-E) (Ueoka, C., Kaneda, N., Okazaki, I., Nadanaka, S., Muramatsu, T., and Sugahara, K. (2000) J. Biol. Chem. 275, 37407-37413) and that CS-E exhibits neurite outgrowth promoting activities toward embryonic rat hippocampal neurons. We have also shown oversulfated CS chains in embryonic chick and rat brains and demonstrated that the CS disaccharide composition changes during brain development. In view of these findings, here we tested the possibility of CS-E interacting with Hep-binding growth factors during development, using squid cartilage CS-E. The binding ability of Hep-binding growth factors (MK, pleiotrophin (PTN), fibroblast growth factor-1 (FGF-1), FGF-2, Hep-binding epidermal growth factor-like growth factor (HB-EGF), FGF-10, FGF-16, and FGF-18) toward [(3)H]CS-E was first tested by a filter binding assay, which demonstrated direct binding of all growth factors, except FGF-1, to CS-E. The bindings were characterized further in an Interaction Analysis system, where all of the growth factors, except FGF-1, gave concentration-dependent and specific bindings. The kinetic constants k(a), k(d), and K(d) suggested that MK, PTN, FGF-16, FGF-18, and HB-EGF bound strongly to CS-E, in comparable degrees to the binding to Hep, whereas the intensity of binding of FGF-2 and FGF-10 toward CS-E was lower than that for Hep. These findings suggest the possibility of CS-E being a binding partner, a coreceptor, or a genuine receptor for various Hep-binding growth factors in the brain and possibly also in other tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221095     DOI: 10.1074/jbc.M207105200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  112 in total

1.  Semi-synthesis of chondroitin sulfate-E from chondroitin sulfate-A.

Authors:  Chao Cai; Kemal Solakyildirim; Bo Yang; Julie M Beaudet; Amanda Weyer; Robert J Linhardt; Fuming Zhang
Journal:  Carbohydr Polym       Date:  2012-01-04       Impact factor: 9.381

2.  End-functionalized glycopolymers as mimetics of chondroitin sulfate proteoglycans.

Authors:  Song-Gil Lee; Joshua M Brown; Claude J Rogers; John B Matson; Chithra Krishnamurthy; Manish Rawat; Linda C Hsieh-Wilson
Journal:  Chem Sci       Date:  2010-09-01       Impact factor: 9.825

Review 3.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 4.  Chondroitin sulfate "wobble motifs" modulate maintenance and differentiation of neural stem cells and their progeny.

Authors:  Anurag Purushothaman; Kazuyuki Sugahara; Andreas Faissner
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

5.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

6.  Mice deficient in N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase are unable to synthesize chondroitin/dermatan sulfate containing N-acetylgalactosamine 4,6-bissulfate residues and exhibit decreased protease activity in bone marrow-derived mast cells.

Authors:  Shiori Ohtake-Niimi; Sachiko Kondo; Tatsuro Ito; Saori Kakehi; Tadayuki Ohta; Hiroko Habuchi; Koji Kimata; Osami Habuchi
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

7.  Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans.

Authors:  Gregory M Miller; Linda C Hsieh-Wilson
Journal:  Exp Neurol       Date:  2015-08-24       Impact factor: 5.330

8.  Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.

Authors:  Anurag Purushothaman; Douglas R Hurst; Claudio Pisano; Shuji Mizumoto; Kazuyuki Sugahara; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

9.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

10.  Inhibition of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase by beta-D-4-O-sulfo-N-acetylgalactosaminides bearing various hydrophobic aglycons.

Authors:  Hiroko Nozaki; Yuri Tomoyama; Hideyuki Takagi; Koutaro Yokoyama; Chika Yamada; Ken-ichi Kaio; Masaki Tsukimori; Kazuya Nagao; Yuya Itakura; Shiori Ohtake-Niimi; Hirofumi Nakano; Osami Habuchi
Journal:  Glycoconj J       Date:  2009-12-18       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.